Loading...
Docoh

Kange (KGNR)

Cover

Cover - shares9 Months Ended
Aug. 31, 2018Jun. 08, 2021
Cover [Abstract]
Entity Registrant NameKANGE CORP.
Entity Central Index Key0001593773
Document Type10-Q
Amendment Flagfalse
Current Fiscal Year End Date--11-30
Entity Small Businesstrue
Entity Shell Companyfalse
Entity Emerging Growth Companyfalse
Entity Current Reporting StatusNo
Document Period End DateAug. 31,
2018
Entity Filer CategoryNon-accelerated Filer
Document Fiscal Period FocusQ3
Document Fiscal Year Focus2018
Entity Common Stock Shares Outstanding14,553,465
Document Quarterly Reporttrue
Document Transition Reportfalse
Entity File Number333-194055
Entity Incorporation State Country CodeNV
Entity Tax Identification Number33-1230169
Entity Address Address Line 111724 Ventura Blvd Suite B
Entity Address City Or TownStudio City
Entity Address State Or ProvinceCA
Entity Address Postal Zip Code91604
City Area Code818
Local Phone Number853-7033
Entity Interactive Data CurrentYes

Balance Sheets

Balance Sheets - USD ($)Aug. 31, 2018Nov. 30, 2017
Current Assets
Cash $ 0 $ 77
Marketable securities16,200 81,000
Prepaid expenses12,920 66,312
Total Current Assets29,120 147,389
TOTAL ASSETS29,120 147,389
Current Liabilities
Accounts payable and accrued liabilities11,006 5,250
Accrued expenses - related party6,000 1,000
Due to related parties0 26,901
Total Current Liabilities17,006 33,151
Stockholders' Equity
Common stock, $0.001 par value, 750,000,000 shares authorized, 14,553,465 and 14,165,842 shares issued and outstanding, respectively.14,553 14,166
Additional paid-in capital1,292,474 808,332
Accumulated deficit(1,294,913)(708,260)
Total Stockholders' Equity12,114 114,238
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 29,120 $ 147,389

Balance Sheets (Parenthetical)

Balance Sheets (Parenthetical) - $ / sharesAug. 31, 2018Nov. 30, 2017
Stockholders' deficit
Common stock, Par value $ 0.001 $ 0.001
Common stock, Authorized750,000,000 750,000,000
Common Stock, Shares Issued14,553,465 14,165,842
Common stock, Shares Outstanding14,553,465 14,165,842

Statements of Operations (Unaud

Statements of Operations (Unaudited) - USD ($)3 Months Ended9 Months Ended
Aug. 31, 2018Aug. 31, 2017Aug. 31, 2018Aug. 31, 2017
Statements of Operations (Unaudited)
Revenues $ 0 $ 0 $ 0 $ 0
Operating Expenses
General and administrative3,300 2,049 16,083 16,629
Consulting12,099 76,000 53,392 76,000
Total operating expenses15,399 78,049 69,475 92,629
Operating loss(15,399)(78,049)(69,475)(92,629)
Other expenses
Interest expense0 (1,642)0 (4,896)
Amortization of debt discount0 0 0 (2,170)
Loss on settlement of debt - related party0 0 (452,378)0
Unrealized loss on marketable securities(28,929)0 (64,800)0
Total other expenses(28,929)(1,642)(517,178)(7,066)
Net loss $ (44,328) $ (79,691) $ (586,653) $ (99,695)
Basic and diluted loss per common share $ 0 $ (0.01) $ (0.04) $ (0.01)
Basic and diluted weighted average common shares outstanding14,553,465 10,576,196 14,419,559 10,572,080

Statement of Changes in Stockho

Statement of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($)TotalCommon StockAdditional Paid-In CapitalAccumulated Deficit
Balance, shares at Nov. 30, 201610,570,000
Balance, amount at Nov. 30, 2016 $ (68,405) $ 10,570 $ 541,253 $ (620,228)
Net loss for the period(11,186) $ 0 0 (11,186)
Balance, shares at Feb. 28, 201710,570,000
Balance, amount at Feb. 28, 2017(79,591) $ 10,570 541,253 (631,414)
Balance, shares at Nov. 30, 201610,570,000
Balance, amount at Nov. 30, 2016(68,405) $ 10,570 541,253 (620,228)
Net loss for the period(99,695)
Balance, shares at Aug. 31, 201710,665,000
Balance, amount at Aug. 31, 2017(92,100) $ 10,665 617,158 (719,923)
Balance, shares at Feb. 28, 201710,570,000
Balance, amount at Feb. 28, 2017(79,591) $ 10,570 541,253 (631,414)
Net loss for the period(8,818) $ 0 0 (8,818)
Balance, shares at May. 31, 201710,570,000
Balance, amount at May. 31, 2017(88,409) $ 10,570 541,253 (640,232)
Net loss for the period(79,691) $ 0 0 (79,691)
Shares issued for services, shares95,000
Shares issued for services, amount76,000 $ 95 75,905 0
Balance, shares at Aug. 31, 201710,665,000
Balance, amount at Aug. 31, 2017(92,100) $ 10,665 617,158 (719,923)
Balance, shares at Nov. 30, 201714,165,842
Balance, amount at Nov. 30, 2017114,238 $ 14,166 808,332 (708,260)
Net loss for the period3,463 $ 0 0 3,463
Balance, shares at Feb. 28, 201814,165,842
Balance, amount at Feb. 28, 2018117,701 $ 14,166 808,332 (704,797)
Balance, shares at Nov. 30, 201714,165,842
Balance, amount at Nov. 30, 2017114,238 $ 14,166 808,332 (708,260)
Net loss for the period(586,653)
Balance, shares at Aug. 31, 201814,553,465
Balance, amount at Aug. 31, 201812,114 $ 14,553 1,292,474 (1,294,913)
Balance, shares at Feb. 28, 201814,165,842
Balance, amount at Feb. 28, 2018117,701 $ 14,166 808,332 (704,797)
Net loss for the period(545,788) $ 0 0 (545,788)
Shares issued for debt settlement, shares387,623
Shares issued for debt settlement, amount484,529 $ 387 484,142 0
Balance, shares at May. 31, 201814,553,465
Balance, amount at May. 31, 201856,442 $ 14,553 1,292,474 (1,250,585)
Net loss for the period(44,328) $ 0 0 (44,328)
Balance, shares at Aug. 31, 201814,553,465
Balance, amount at Aug. 31, 2018 $ 12,114 $ 14,553 $ 1,292,474 $ (1,294,913)

Statements of Cash Flows (Unaud

Statements of Cash Flows (Unaudited) - USD ($)9 Months Ended
Aug. 31, 2018Aug. 31, 2017
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss $ (586,653) $ (99,695)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of debt discount0 2,170
Unrealized loss on marketable securities64,800 0
Loss on settlement of debt452,378 0
Issuance of common stock for services0 76,000
Changes in operating assets and liabilities:
Prepaid expenses53,392 0
Accounts payable and accrued liabilities5,756 4,882
Accrued expenses to related party9,000 4,896
Net cash used in operating activities(1,327)(11,747)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from loan from related party1,250 11,669
Net cash provided by financing activities1,250 11,669
Net change in cash for the period(77)(78)
Cash at beginning of period77 155
Cash at end of period0 77
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for income taxes0 0
Cash paid for interest0 0
NON-CASH INVESTING AND FINANCING ACTIVITIES
Stock issued for debt to related party $ 484,529 $ 0

ORGANIZATION AND NATURE OF BUSI

ORGANIZATION AND NATURE OF BUSINESS9 Months Ended
Aug. 31, 2018
ORGANIZATION AND NATURE OF BUSINESS
NOTE 1 - ORGANIZATION AND NATURE OF BUSINESSNOTE 1 – ORGANIZATION AND NATURE OF BUSINESS Organization Kange Corp. ("Kange," the "Company," "we," "us," or "our") was incorporated under the laws of the State of Nevada on August 16, 2013. We are a start-up company developing mobile software products for Apple and Android platforms, starting in Estonia and Europe, which is our initial intended market. Apple is a trademark of Apple Inc., and Android is a trademark of Alphabet Inc. During 2017, we began focusing on the intersection of technology and wholistic technology-based health treatments. We retained an advisor having substantial experience in the technology sector, and two former professional athletes to advise us regarding sports health issues and treatments. We intend to provide services to formulate a treatment model to meet the needs of professional athletes that suffer from PTSD and the early onset of dementia and Alzheimer’s. The Company is currently evaluating operations in the wholistic health industry. Basis of Presentation The accompanying unaudited financial statements of the Company are condensed and have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”), including the instructions to Form 10-Q and Regulation S-X. Certain information and note disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”), have been condensed or omitted from these statements pursuant to such rules and regulations and, accordingly, they do not include all the information and notes necessary for comprehensive financial statements and should be read in conjunction with our audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended November 30, 2017. The results of operations for the period ended August 31, 2018 are not necessarily indicative of the operating results for the full year. Fair Value of Financial Instruments The Company measures its financial assets and liabilities in accordance with generally accepted accounting principles. For certain of our financial instruments, including cash, accounts payable, accrued expenses, and short-term loans the carrying amounts approximate fair value due to their short maturities. The Company uses a three-tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement. The hierarchy requires the Company to use observable inputs when available, and to minimize the use of unobservable inputs, when determining fair value. The three tiers are defined as follows: ● Level 1—Observable inputs that reflect quoted market prices (unadjusted) for identical assets or liabilities in active markets; ● Level 2—Observable inputs other than quoted prices in active markets that are observable either directly or indirectly in the marketplace for identical or similar assets and liabilities; and ● Level 3—Unobservable inputs that are supported by little or no market data, which require the Company to develop its own assumptions. The Company’s financial instruments, including cash, accounts payable, accrued expenses, and due to related parties are carried at historical cost. At August 31, 2018 and November 30, 2017, the carrying amounts of these instruments approximated their fair values because of the short-term nature of these instruments. The Company values marketable securities as level 1 and are measured at fair value. Going Concern The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company used cash in operating activities of $1,327 for the nine months ended August 31, 2018. The Company had an accumulated deficit of $1,294,913 at August 31, 2018. These factors raise substantial doubt about the ability of the Company to continue as a going concern for a reasonable period of time. The Company's continuation as a going concern is dependent upon its ability to generate revenues and its ability to continue receiving investment capital and loans from related parties to sustain its current level of operations. The Company is in the process of securing working capital from investors for common stock, convertible notes payable, and/or strategic partnerships. No assurance can be given that the Company will be successful in these efforts. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. The estimates and judgments will also affect the reported amounts for certain expenses during the reporting period. Actual results could differ from these good faith estimates and judgments. Net Earnings (Loss) Per Share In accordance with ASC 260-10, "Earnings per Share," basic net earnings (loss) per common share is computed by dividing the net earnings (loss) for the period by the weighted average number of common shares outstanding during the period. Diluted earnings (loss) per share is computed using the weighted average number of common and dilutive common stock equivalent shares outstanding during the period, which are excluded from the computation if anti-dilutive. There are no dilutive or potentially dilutive securities outstanding during the periods presented. Recent Accounting Pronouncements The Company reviews new accounting pronouncements as issued. Except as disclosed in Note 2, no new pronouncements had any material effect on these financial statements. The accounting pronouncements issued subsequent to the date of these financial statements that were considered significant by management were evaluated for the potential effect on these financial statements. Management does not believe any of the subsequent pronouncements will have a material effect on these financial statements as presented and does not anticipate the need for any future restatement of these financial statements because of the retro-active application of any accounting pronouncements issued subsequent to August 31, 2018 through the date these financial statements were issued.

PREPAID EXPENSES

PREPAID EXPENSES9 Months Ended
Aug. 31, 2018
PREPAID EXPENSES
NOTE 2 - PREPAID EXPENSESNOTE 2 – PREPAID EXPENSES During the year ended November 30, 2017, the Company issued a total of 155,000 shares of common stock to five separate consultants pursuant to advisory board agreements. Three advisory board agreements were made effective on May 25, 2017 with terms of 15,000 shares each to be issued for one year of services to be rendered. Two advisory board agreements were made effective on October 1, 2017 with terms of 30,000 shares each to be issued for one year of services. The Company valued the advisory agreement shares based on the closing stock price of the Company on the date of the executed agreement (the grant date), which resulted in a total combined value of $124,000 initially recorded as prepaid expense to be amortized ratably over the contract term. During the nine months ended August 31, 2018, the Company recorded consulting expense in the amount of $53,392, resulting in the remaining balance of prepaid expense, the uncompleted portion of the contract, of $12,920 and $66,312 at August 31, 2018 and November 30, 2017, respectively

MARKETABLE SECURITIES

MARKETABLE SECURITIES9 Months Ended
Aug. 31, 2018
MARKETABLE SECURITIES
NOTE 3 - MARKETABLE SECURITIESNOTE 3 – MARKETABLE SECURITIES We adopted ASU 2016-01 on December 1, 2017, which requires us to measure all equity investments that do not result in consolidation and are not accounted for under the equity method at fair value and recognize any changes in earnings. We use quoted market prices to determine the fair value of equity securities with readily determinable fair values. On November 1, 2017 the Company executed a stock purchase agreement (the “SPA”) with AMJ Global Entertainment, LLC, a related party and holder of 4,803,195 shares of common stock in Patient Access Solutions Inc., a Nevada corporation with ticker symbol “PASO”. Pursuant to the SPA, the Company issued 158,824 shares of common stock in exchange for 1,157,142 shares of Patient Access Solutions Inc. On November 1, 2017, the Company recorded the shares of Patient Access Solutions Inc. at $81,000. As of August 31, 2018, based quoted market prices, the Company recognized an unrealized loss of $64,800. The carrying values and unrealized loss of our equity securities were included in the following line items in our balance sheets and statements of operations: Fair Value Measurements (Level 1) Marketable securities at November 30, 2017 $ 81,000 Addition of equity securities - Net unrealized loss recognized during the period related to equity securities still held at the end of the period (64,800 ) Marketable securities at August 31, 2018 $ 16,200

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS9 Months Ended
Aug. 31, 2018
RELATED PARTY TRANSACTIONS
NOTE 4 - RELATED PARTY TRANSACTIONSNOTE 4 – RELATED PARTY TRANSACTIONS In support of the Company's efforts and cash requirements, it may rely on advances from related parties until such time that the Company can support its operations or attains adequate financing through sales of its equity or traditional debt financing. There is no formal written commitment for continued support by shareholders. Amounts represent advances or amounts paid in satisfaction of liabilities. The advances are non-interest bearing, considered temporary in nature, and have not been formalized by a promissory note. On November 1, 2017, the Company entered into a one-year office lease agreement with AMJ Global Entertainment LLC, a related party controlled by the Company’s CEO and director, ending November 2, 2018. The location of the leased office space is 11724 Ventura Blvd Suite B, Studio City, California 91604. The lease states monthly rent due of $1,000. During the nine months ended August 31, 2018, the Company accrued $9,000 due to related party. As of August 31, 2018 and November 30, 2017, the Company has accrued lease expense due to related party of $6,000 and $1,000, respectively. At November 30, 2017, the Company owed $26,901 to AMJ Global Entertainment LLC, a related party controlled by the Company’s CEO and director. The amount is unsecured, non-interest bearing and due on demand. During the nine months ended August 31, 2018 and 2017, the Company received proceeds of $1,250 and $11,669, respectively, from the related party. On March 5, 2018, the Company settled the loans totaling $28,151 plus $4,000 of accrued related party lease expense by the issuance of 387,623 shares of common stock valued at $484,529. As a result, the Company recorded a loss on settlement of debt of $452,378.

COMMON STOCK

COMMON STOCK9 Months Ended
Aug. 31, 2018
COMMON STOCK
NOTE 5 - COMMON STOCKNOTE 5 – COMMON STOCK Common Stock The Company has authorized common shares of 750,000,000, par value $0.001 per share. Each outstanding share of common stock entitles the holder to one vote per share on all matters submitted to a stockholder vote. All shares of common stock are non-assessable and non-cumulative, with no pre-emptive rights. On March 5, 2018, the Company issued 387,623 shares of common stock valued at $484,529 to settle debt of $32,151 owed to a related party (Note 3). There were 14,553,465 and 14,165,842 shares of common stock issued and outstanding as of August 31, 2018 and November 30, 2017, respectively.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS9 Months Ended
Aug. 31, 2018
SUBSEQUENT EVENTS
NOTE 6 - SUBSEQUENT EVENTSNOTE 6 – SUBSEQUENT EVENTS On January 13, 2020, the transaction related to stock purchase agreement with AMJ Global Entertainment, LLC, a related party and holder of 4,803,195 shares of common stock in Patient Access Solutions Inc. (see Note 2), was rescinded, and the Company will return 1,157,142 shares of Patient Access Solutions Inc. back to AMJ Global Entertainment, LLC in exchange for 157,142 shares of the Company. The Company has evaluated events occurring subsequent to the balance sheet date through the date these financial statements were issued, and determined there are no additional events requiring disclosure.

ORGANIZATION AND NATURE OF BU_2

ORGANIZATION AND NATURE OF BUSINESS (Policies)9 Months Ended
Aug. 31, 2018
ORGANIZATION AND NATURE OF BUSINESS
OrganizationKange Corp. ("Kange," the "Company," "we," "us," or "our") was incorporated under the laws of the State of Nevada on August 16, 2013. We are a start-up company developing mobile software products for Apple and Android platforms, starting in Estonia and Europe, which is our initial intended market. Apple is a trademark of Apple Inc., and Android is a trademark of Alphabet Inc. During 2017, we began focusing on the intersection of technology and wholistic technology-based health treatments. We retained an advisor having substantial experience in the technology sector, and two former professional athletes to advise us regarding sports health issues and treatments. We intend to provide services to formulate a treatment model to meet the needs of professional athletes that suffer from PTSD and the early onset of dementia and Alzheimer’s. The Company is currently evaluating operations in the wholistic health industry.
Basis of PresentationThe accompanying unaudited financial statements of the Company are condensed and have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”), including the instructions to Form 10-Q and Regulation S-X. Certain information and note disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”), have been condensed or omitted from these statements pursuant to such rules and regulations and, accordingly, they do not include all the information and notes necessary for comprehensive financial statements and should be read in conjunction with our audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended November 30, 2017. The results of operations for the period ended August 31, 2018 are not necessarily indicative of the operating results for the full year.
Fair Value of Financial InstrumentsThe Company measures its financial assets and liabilities in accordance with generally accepted accounting principles. For certain of our financial instruments, including cash, accounts payable, accrued expenses, and short-term loans the carrying amounts approximate fair value due to their short maturities. The Company uses a three-tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement. The hierarchy requires the Company to use observable inputs when available, and to minimize the use of unobservable inputs, when determining fair value. The three tiers are defined as follows: ● Level 1—Observable inputs that reflect quoted market prices (unadjusted) for identical assets or liabilities in active markets; ● Level 2—Observable inputs other than quoted prices in active markets that are observable either directly or indirectly in the marketplace for identical or similar assets and liabilities; and ● Level 3—Unobservable inputs that are supported by little or no market data, which require the Company to develop its own assumptions. The Company’s financial instruments, including cash, accounts payable, accrued expenses, and due to related parties are carried at historical cost. At August 31, 2018 and November 30, 2017, the carrying amounts of these instruments approximated their fair values because of the short-term nature of these instruments. The Company values marketable securities as level 1 and are measured at fair value.
Going ConcernThe accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company used cash in operating activities of $1,327 for the nine months ended August 31, 2018. The Company had an accumulated deficit of $1,294,913 at August 31, 2018. These factors raise substantial doubt about the ability of the Company to continue as a going concern for a reasonable period of time. The Company's continuation as a going concern is dependent upon its ability to generate revenues and its ability to continue receiving investment capital and loans from related parties to sustain its current level of operations. The Company is in the process of securing working capital from investors for common stock, convertible notes payable, and/or strategic partnerships. No assurance can be given that the Company will be successful in these efforts. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.
Use of EstimatesThe preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. The estimates and judgments will also affect the reported amounts for certain expenses during the reporting period. Actual results could differ from these good faith estimates and judgments.
Net Earnings (Loss) Per ShareIn accordance with ASC 260-10, "Earnings per Share," basic net earnings (loss) per common share is computed by dividing the net earnings (loss) for the period by the weighted average number of common shares outstanding during the period. Diluted earnings (loss) per share is computed using the weighted average number of common and dilutive common stock equivalent shares outstanding during the period, which are excluded from the computation if anti-dilutive. There are no dilutive or potentially dilutive securities outstanding during the periods presented.
Recent Accounting PronouncementsThe Company reviews new accounting pronouncements as issued. Except as disclosed in Note 2, no new pronouncements had any material effect on these financial statements. The accounting pronouncements issued subsequent to the date of these financial statements that were considered significant by management were evaluated for the potential effect on these financial statements. Management does not believe any of the subsequent pronouncements will have a material effect on these financial statements as presented and does not anticipate the need for any future restatement of these financial statements because of the retro-active application of any accounting pronouncements issued subsequent to August 31, 2018 through the date these financial statements were issued.

MARKETABLE SECURITIES (Tables)

MARKETABLE SECURITIES (Tables)9 Months Ended
Aug. 31, 2018
MARKETABLE SECURITIES
Schedule of value of equity securitiesFair Value Measurements (Level 1) Marketable securities at November 30, 2017 $ 81,000 Addition of equity securities - Net unrealized loss recognized during the period related to equity securities still held at the end of the period (64,800 ) Marketable securities at August 31, 2018 $ 16,200

ORGANIZATION AND NATURE OF BU_3

ORGANIZATION AND NATURE OF BUSINESS (Details Narrative) - USD ($)9 Months Ended
Aug. 31, 2018Aug. 31, 2017Nov. 30, 2017
ORGANIZATION AND NATURE OF BUSINESS
Net cash used in operating activities $ (1,327) $ (11,747)
Accumulated deficit $ (1,294,913) $ (708,260)

PREPAID EXPENSES (Details Narra

PREPAID EXPENSES (Details Narrative) - USD ($)1 Months Ended9 Months Ended12 Months Ended
May 25, 2017Aug. 31, 2018Nov. 30, 2017
Remaining balance of prepaid expense $ 12,920 $ 66,312
Consulting expense53,392
Initially Prepaid expense $ 124,000
Shares issued for services rendered30,000
Advisory Board Agreements [Member]
Shares issued for services rendered15,000
Issuance shares of common stock155,000

MARKETABLE SECURITIES (Details)

MARKETABLE SECURITIES (Details)9 Months Ended
Aug. 31, 2018USD ($)
Equity securities at November 30, 2017 $ 81,000
Net unrealized loss recognized during the period related to equity securities still held at the end of the period(64,800)
Equity securities at August 31, 201816,200
Fair Value Measurements (Level 1) [Member]
Equity securities at November 30, 201781,000
Addition of equity securities0
Net unrealized loss recognized during the period related to equity securities still held at the end of the period(64,800)
Equity securities at August 31, 2018 $ 16,200

MARKETABLE SECURITIES (Details

MARKETABLE SECURITIES (Details Narrative) - USD ($)Jan. 13, 2020Nov. 01, 2017Aug. 31, 2018Nov. 30, 2017
Exchange Common Stock Value $ 81,000
Unrealized gain on investment $ (64,800)
Common stock, shares issued14,553,465 14,165,842
Patient Access Solutions Inc [Member]
Common stock, shares issued158,824
Common stock, shares returned in exchange during period1,157,142
Amj Global Entertainment LLc [Member]
Common stock, shares rescinded during period4,803,195 4,803,195

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)Mar. 05, 2018May 25, 2017Aug. 31, 2017Aug. 31, 2018Aug. 31, 2017Nov. 30, 2017
Due to related party $ 0 $ 26,901
Accrued expenses - related party6,000 1,000
Common Stock, Shares Issued During Period, Shares30,000
Common Stock, Shares Issued During Period, Value $ 76,000
Amj Global [Member]
Due to related party6,000 $ 1,000
Accrued expenses - related party $ 4,000 9,000
Settlement of loan amount $ 28,151
Monthly rent of lease1,000
Proceeds from the related party1,250 $ 11,669
Common Stock, Shares Issued During Period, Shares387,623
Common Stock, Shares Issued During Period, Value $ 484,529
Loss on settlement of debt $ 452,378

COMMON STOCK (Details Narrative

COMMON STOCK (Details Narrative) - USD ($)Mar. 05, 2018May 25, 2017Aug. 31, 2017Aug. 31, 2018Nov. 30, 2017
Common stock, Authorized750,000,000 750,000,000
Common stock, Par value $ 0.001 $ 0.001
Common Stock, Shares Issued14,553,465 14,165,842
Common stock, Shares Outstanding14,553,465 14,165,842
Common Stock, Shares Issued During Period, Shares30,000
Common Stock, Shares Issued During Period, Value $ 76,000
Amj Global [Member]
Settlement of loan amount $ 32,151
Common Stock, Shares Issued During Period, Shares387,623
Common Stock, Shares Issued During Period, Value $ 484,529

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - sharesJan. 13, 2020Nov. 01, 2017
Subsequent Event [Member]
Common stock, shares returned1,157,142
Amj Global Entertainment LLc [Member]
Common stock, shares rescinded during period4,803,195 4,803,195
Amj Global Entertainment LLc [Member] | Subsequent Event [Member]
Common stock, shares returned in exchange during period157,142